RecruitingPhase 2NCT05886036

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

Studying Nodular lymphocyte predominant Hodgkin lymphoma

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Cancer Institute (NCI)
Principal Investigator: Raphael E Steiner, MD
University of Texas MD Anderson Cancer Center LAO
Intervention: Biopsy Procedure(procedure)
Enrollment: 70 enrolled
Eligibility: 18 years · All sexes
Timeline: 2024 – 2026

Study locations (30)

City of Hope Comprehensive Cancer Center, Duarte, California, United States
UM Sylvester Comprehensive Cancer Center at Aventura, Aventura, Florida, United States
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States
UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs, Florida, United States
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States
UM Sylvester Comprehensive Cancer Center at Doral, Doral, Florida, United States
UM Sylvester Comprehensive Cancer Center at Hollywood, Hollywood, Florida, United States
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, United States
UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
University of Kansas Cancer Center, Kansas City, Kansas, United States
University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States
University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States
University of Kansas Cancer Center - Briarcliff, Kansas City, Missouri, United States
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05886036 on ClinicalTrials.gov

Other trials for Nodular lymphocyte predominant Hodgkin lymphoma

Additional recruiting or active studies for the same condition.

RECRUITINGNCT06098430
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
St. Jude Children's Research Hospital

See all trials for Nodular lymphocyte predominant Hodgkin lymphoma →

← Back to all trials